Survival Benefits of Extracorporeal Membrane Oxygenation for Selected Patients With Severe COVID-19.
作者信息
Dandel Michael
机构信息
German Centre for Cardiovascular Research (DZHK), Potsdamer Str 58, 10785 Berlin, Germany.
出版信息
Ann Thorac Surg. 2023 Apr;115(4):1085-1086. doi: 10.1016/j.athoracsur.2022.04.012. Epub 2022 Apr 25.
Abstract
摘要
相似文献
1
Survival Benefits of Extracorporeal Membrane Oxygenation for Selected Patients With Severe COVID-19.体外膜肺氧合对部分重症新型冠状病毒肺炎患者的生存获益
Ann Thorac Surg. 2023 Apr;115(4):1085-1086. doi: 10.1016/j.athoracsur.2022.04.012. Epub 2022 Apr 25.
2
Posthospitalization outcomes after extracorporeal membrane oxygenation (ECMO) for COVID-19.COVID-19 患者体外膜肺氧合（ECMO）后的住院后结局。
Surgery. 2022 Jul;172(1):466-469. doi: 10.1016/j.surg.2022.01.044. Epub 2022 Feb 8.
3
Treatment of acute respiratory distress syndrome from COVID-19 with extracorporeal membrane oxygenation in obstetrical patients.产科患者中使用体外膜肺氧合治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征
Am J Obstet Gynecol MFM. 2022 Mar;4(2):100537. doi: 10.1016/j.ajogmf.2021.100537. Epub 2021 Nov 20.
4
Use of Extracorporeal Membrane Oxygenation Therapy During Pregnancy and COVID-19: A Case Study.妊娠期使用体外膜肺氧合治疗COVID-19：病例研究。
AACN Adv Crit Care. 2022 Sep 15;33(3):247-252. doi: 10.4037/aacnacc2022111.
5
Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
6
Rehabilitation for COVID-19 in conjunction with early awake extracorporeal membrane oxygenation support: a case report.COVID-19 康复治疗联合早期清醒体外膜肺氧合支持：病例报告。
Int J Rehabil Res. 2022 Sep 1;45(3):287-290. doi: 10.1097/MRR.0000000000000533. Epub 2022 Jun 22.
7
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19.体外膜肺氧合治疗重症 COVID-19 后 6 个月的存活率。
J Cardiothorac Vasc Anesth. 2021 Jul;35(7):1999-2006. doi: 10.1053/j.jvca.2021.01.027. Epub 2021 Jan 19.
8
Implementation of care for the use of the extracorporeal oxygenation membrane in the COVID-19 pandemic.实施 COVID-19 大流行期间体外膜氧合的护理。
Rev Bras Enferm. 2021 Apr 14;74Suppl 1(Suppl 1):e20200870. doi: 10.1590/0034-7167-2020-0870. eCollection 2021.
9
Predicting Mortality for Patients Eligible for Extracorporeal Membrane Oxygenation for COVID-19.预测符合COVID-19体外膜肺氧合治疗条件患者的死亡率
Am J Respir Crit Care Med. 2022 Sep 1;206(5):628-632. doi: 10.1164/rccm.202202-0237LE.
10
Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.体外膜肺氧合联合右心室辅助装置治疗 COVID-19 相关急性呼吸窘迫综合征。
J Surg Res. 2021 Aug;264:81-89. doi: 10.1016/j.jss.2021.03.017. Epub 2021 Mar 18.
引用本文的文献
1
Monitoring of the right ventricular responses to pressure overload: prognostic value and usefulness of echocardiography for clinical decision-making.监测右心室对压力超负荷的反应：超声心动图对临床决策的预后价值及实用性。
Cardiovasc Diagn Ther. 2024 Feb 15;14(1):193-222. doi: 10.21037/cdt-23-380. Epub 2024 Feb 1.
2
Improving Outcomes for Patients With Severe COVID-19 Acute Respiratory Distress Syndrome Supported With Extracorporeal Membrane Oxygenation.改善接受体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的预后
Ann Thorac Surg. 2023 Apr;115(4):1086-1087. doi: 10.1016/j.athoracsur.2022.06.025. Epub 2022 Jul 3.
Zotero 插件